-
Start Preamble
Start Printed Page 21814
AGENCY:
Drug Enforcement Administration, Department of Justice.
ACTION:
Order with opportunity for comment.
SUMMARY:
The applications for exempt chemical preparations received by the Drug Enforcement Administration (DEA) between July 1, 2018, and December 31, 2020, as listed below, were accepted for filing and have been approved or denied as indicated.
DATES:
Interested persons may file written comments on this order in accordance with 21 CFR 1308.23(e). Electronic comments must be submitted, and written comments must be postmarked, on or before June 22, 2021. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period.
ADDRESSES:
To ensure proper handling of comments, please reference “Docket No. DEA-372” on all correspondence, including any attachments.
Electronic comments: DEA encourages that all comments be submitted through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or to attach a file for lengthier comments. Please go to http://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon completion of your submission you will receive a Comment Tracking Number for your comment. Please be aware that submitted comments are not instantaneously available for public view on Regulations.gov. If you have received a comment tracking number, your comment has been successfully submitted and there is no need to resubmit the same comment.
Paper comments: Paper comments that duplicate the electronic submission are not necessary and are discouraged. Should you wish to mail a comment in lieu of an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Terrence L. Boos, Ph.D., Diversion Control Division, Drug Enforcement Administration; Telephone: (571) 362-8201.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Posting of Public Comments
Please note that all comments received are considered part of the public record and made available for public inspection online at http://www.regulations.gov and in the DEA's public docket. Such information includes personal identifying information (such as your name, address, etc.) voluntarily submitted by the commenter. The Freedom of Information Act applies to all comments received.
If you want to submit personal identifying information (such as your name, address, etc.) as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase “PERSONAL IDENTIFYING INFORMATION” in the first paragraph of your comment. You must also place all the personal identifying information you do not want posted online or made available in the public docket in the first paragraph of your comment and identify what information you want redacted.
If you want to submit confidential business information as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase “CONFIDENTIAL BUSINESS INFORMATION” in the first paragraph of your comment. You must also prominently identify confidential business information to be redacted within the comment.
Comments containing personal identifying information and confidential business information identified as directed above will generally be made publicly available in redacted form. If a comment has so much confidential business information that it cannot be effectively redacted, all or part of that comment may not be made publicly available. Comments posted to http://www.regulations.gov may include any personal identifying information (such as name, address, and phone number) included in the text of your electronic submission that is not identified as directed above as confidential.
An electronic copy of this document is available at http://www.regulations.gov for easy reference.
Legal Authority
Section 201 of the Controlled Substances Act (CSA) (21 U.S.C. 811) authorizes the Attorney General, by regulation, to exempt from certain provisions of the CSA certain compounds, mixtures, or preparations containing a controlled substance, if he finds that such compounds, mixtures, or preparations meet the requirements detailed in 21 U.S.C. 811(g)(3)(B).[1] The DEA regulations at 21 CFR 1308.23 and 1308.24 further detail the criteria by which the DEA Assistant Administrator may exempt a chemical preparation or mixture from certain provisions of the CSA. The Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify or revoke the criteria by which exemptions are granted and modify the scope of exemptions at any time.
Exempt Chemical Preparation Applications Submitted Between July 1, 2018, and December 31, 2020
The Assistant Administrator received applications between July 1, 2018, and December 31, 2020, requesting exempt chemical preparation status detailed in 21 CFR 1308.23. Pursuant to the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart I below is intended for laboratory, industrial, educational, or special research purposes and not for general administration to a human being or animal and either: (1) Contains no narcotic controlled substance and is packaged in such a form or concentration that the packaged quantity does not present any significant potential for abuse; or (2) contains either a narcotic or non-narcotic controlled substance and one or more adulterating or denaturing agents in such a manner, combination, quantity, proportion, or concentration that the preparation or mixture does not present any potential for abuse and, if the preparation or mixture contains a narcotic controlled substance, is formulated in such a manner that it incorporates methods of denaturing or other means so that the preparation or mixture is not liable to be abused or have ill effects, if abused, and so that the narcotic substance cannot in practice be removed.
Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23, and 21 CFR 1308.24, the Assistant Administrator has determined that each of the chemical preparations or mixtures generally described in Chart I below and specifically described in the application materials received by DEA is exempt, to the extent described in 21 CFR 1308.24, Start Printed Page 21815from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 (21 U.S.C. 822-823, 825-829, and 952-954) of the CSA, and 21 CFR 1301.74, as of the date that was provided in the approval letters to the individual requesters.
Scope of Approval
The exemptions are applicable only to the precise preparation or mixture described in the application submitted to DEA in the form(s) listed in this order and only for those above mentioned sections of the CSA and the CFR. In accordance with 21 CFR 1308.24(h), any change in the quantitative or qualitative composition of the preparation or mixture, or change in the trade name or other designation of the preparation or mixture after the date of application requires a new application. The requirements set forth in 21 CFR 1308.24(b)-(e) apply to the exempted materials. In accordance with 21 CFR 1308.24(g), DEA may prescribe requirements other than those set forth in 21 CFR 1308.24(b)-(e) on a case-by-case basis for materials exempted in bulk quantities. Accordingly, in order to limit opportunity for diversion from the larger bulk quantities, DEA has determined that each of the exempted bulk products listed in this order may only be used in-house by the manufacturer, and may not be distributed for any purpose, or transported to other facilities.
Additional exempt chemical preparation requests received between July 1, 2018, and December 31, 2020, and not otherwise referenced in this order, may remain under consideration until DEA receives additional information required, pursuant to 21 CFR 1308.23(d), as detailed in separate correspondence to individual requesters. DEA's order on such requests will be communicated to the public in a future Federal Register publication.
DEA also notes that these exemptions are limited to exemption from only those sections of the CSA and the CFR that are specifically identified in 21 CFR 1308.24(a). All other requirements of the CSA and the CFR apply, including registration as an importer as required by 21 U.S.C. 957.
Start Printed Page 21816 Start Printed Page 21817 Start Printed Page 21818 Start Printed Page 21819 Start Printed Page 21820 Start Printed Page 21821 Start Printed Page 21822 Start Printed Page 21823 Start Printed Page 21824 Start Printed Page 21825 Start Printed Page 21826 Start Printed Page 21827 Start Printed Page 21828 Start Printed Page 21829 Start Printed Page 21830 Start Printed Page 21831 Start Printed Page 21832 Start Printed Page 21833 Start Printed Page 21834 Start Printed Page 21835 Start Printed Page 21836 Start Printed Page 21837 Start Printed Page 21838 Start Printed Page 21839 Start Printed Page 21840 Start Printed Page 21841 Start Printed Page 21842 Start Printed Page 21843 Start Printed Page 21844 Start Printed Page 21845 Start Printed Page 21846 Start Printed Page 21847 Start Printed Page 21848 Start Printed Page 21849 Start Printed Page 21850 Start Printed Page 21851 Start Printed Page 21852 Start Printed Page 21853 Start Printed Page 21854 Start Printed Page 21855 Start Printed Page 21856 Start Printed Page 21857 Start Printed Page 21858 Start Printed Page 21859 Start Printed Page 21860 Start Printed Page 21861 Start Printed Page 21862 Start Printed Page 21863 Start Printed Page 21864 Start Printed Page 21865 Start Printed Page 21866 Start Printed Page 21867 Start Printed Page 21868 Start Printed Page 21869 Start Printed Page 21870 Start Printed Page 21871 Start Printed Page 21872 Start Printed Page 21873 Start Printed Page 21874 Start Printed Page 21875 Start Printed Page 21876 Start Printed Page 21877 Start Printed Page 21878 Start Printed Page 21879 Start Printed Page 21880 Start Printed Page 21881 Start Printed Page 21882 Start Printed Page 21883 Start Printed Page 21884 Start Printed Page 21885 Start Printed Page 21886 Start Printed Page 21887 Start Printed Page 21888 Start Printed Page 21889 Start Printed Page 21890 Start Printed Page 21891 Start Printed Page 21892 Start Printed Page 21893 Start Printed Page 21894 Start Printed Page 21895 Start Printed Page 21896 Start Printed Page 21897 Start Printed Page 21898 Start Printed Page 21899 Start Printed Page 21900 Start Printed Page 21901 Start Printed Page 21902 Start Printed Page 21903 Start Printed Page 21904 Start Printed Page 21905 Start Printed Page 21906 Start Printed Page 21907 Start Printed Page 21908 Start Printed Page 21909 Start Printed Page 21910 Start Printed Page 21911Opportunity for Comment
Pursuant to 21 CFR 1308.23(e), any interested person may submit written comments on or objections to any chemical preparation in this order that has been approved or denied as exempt. If any comments or objections raise significant issues regarding any finding of fact or conclusion of law upon which this order is based, the Assistant Administrator will immediately suspend the effectiveness of any applicable part of this order until he may reconsider the application in light of the comments and objections filed. Thereafter, the Assistant Administrator shall reinstate, revoke, or amend his original order as he determines appropriate.
Approved Exempt Chemical Preparations Are Posted on the DEA's Website
A list of all current exemptions, including those listed in this order, is available on the DEA's website at http://www.DEAdiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf. The dates of applications of all current exemptions are posted for easy reference.
Start SignatureWilliam T. McDermott,
Assistant Administrator.
Footnotes
1. This authority has been delegated from the Attorney General to the Administrator of the DEA by 28 CFR 0.100, and subsequently redelegated to the Deputy Assistant Administrator pursuant to 28 CFR 0.104 and Section 7 of the appendix to subpart R of part 0.
Back to Citation
Document Information
- Published:
- 04/23/2021
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Order with opportunity for comment.
- Document Number:
- 2021-06689
- Dates:
- Interested persons may file written comments on this order in accordance with 21 CFR 1308.23(e). Electronic comments must be submitted, and written comments must be postmarked, on or before June 22, 2021. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period.
- Pages:
- 21814-21911 (98 pages)
- Docket Numbers:
- Docket No. DEA-372
- PDF File:
- 2021-06689.pdf